Ipsen封面照片

關於我們

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.

產業
製藥製造
公司規模
5,001-10,000 名員工
總部
Boulogne Billancourt
類型
上市公司
專長
Pharmaceuticals、Specialty care: oncology, neuroscience, endocrinology、Research: peptides, toxins和Primary Care

地點

Ipsen員工

動態消息

相似頁面

融資

Ipsen 總計 1 輪

最近一輪

上市後資產

US$29,134,597.00

Crunchbase 查看更多資訊